The Effects of Ethanol on Intestinal Permeability and Gut Hormones
NCT ID: NCT03348371
Last Updated: 2017-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2016-08-01
2017-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral day
Participant receive ethanol orally
Ethanol
The intervention is two different administrationforms of ethanol, orally and i.v.
i.v. infusion day
Participant receive ethanol in an i.v. infusion
Ethanol
The intervention is two different administrationforms of ethanol, orally and i.v.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ethanol
The intervention is two different administrationforms of ethanol, orally and i.v.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) between 19 and 25 kg/m2
* Weekly alcohol intake of less than 14 units of alcohol (of 12 g)
* Normal fasting plasma glucose concentration (i.e. \<6 mmol/l) and normal glycated haemoglobin A1c (HbA1c) (i.e. ≤42 mmol/mol)
* Normal haemoglobin
* Informed consent
Exclusion Criteria
* Liver disease or other alcohol-related diseases, diabetes mellitus
* Liver disease (serum ALAT and/or serum ASAT \>2 × normal values)
* Nephropathy (serum creatinine above normal range and/or albuminuria)
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amalie Lanng
BA
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AlcoGut
Identifier Type: -
Identifier Source: org_study_id